Literature DB >> 19781967

Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3.

Jianping Lin1, Ralf Buettner, Yate-Ching Yuan, Richard Yip, David Horne, Richard Jove, Nagarajan Vaidehi.   

Abstract

All signal transducers and activators of transcription (STAT) factors are a family of cytoplasmic transcription factors that mediate the signal response to cytokines, growth factors, and hormonal factors. The phosphorylation and subsequent activation of Stat3, a member of the STAT family, has been found to be elevated in a large number of diverse human cancers. Understanding of the dynamics of the Stat3 dimer interface is pertinent to designing small molecule inhibitors to activated Stat3 dimer. To this end, we have performed molecular dynamics simulations in explicit water of the activated Stat3 homodimer, and also its closely related member of the STAT family, activated Stat1 homodimer. We observed a large-scale domain motion in the Stat3 dimer while the structure of the monomer remains intact. The driving force for this conformational change is enhanced binding of the Stat3 dimer to the DNA, thereby regulating gene expression. Our model shows that the carboxy terminus of one monomer wraps around the core of the SH2 domain of the other monomer, and this region that makes up the dimer interface remains intact during the dynamics. Water diffuses into a cavity under this dimer interface, thus expanding a pre-existing cavity that gets gated and closed by the loops in the SH2 domain. This cavity could serve as a potential binding pocket for inhibitor design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19781967     DOI: 10.1016/j.jmgm.2009.08.013

Source DB:  PubMed          Journal:  J Mol Graph Model        ISSN: 1093-3263            Impact factor:   2.518


  12 in total

1.  Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.

Authors:  Ralf Buettner; Renzo Corzano; Rumana Rashid; Jianping Lin; Maheswari Senthil; Michael Hedvat; Anne Schroeder; Allen Mao; Andreas Herrmann; John Yim; Hongzhi Li; Yate-Ching Yuan; Kenichi Yakushijin; Fumiko Yakushijin; Nagarajan Vaidehi; Roger Moore; Gabriel Gugiu; Terry D Lee; Richard Yip; Yuan Chen; Richard Jove; David Horne; John C Williams
Journal:  ACS Chem Biol       Date:  2011-02-16       Impact factor: 5.100

2.  The competitive nature of signal transducer and activator of transcription complex formation drives phenotype switching of T cells.

Authors:  Ildar I Sadreev; Michael Z Q Chen; Yoshinori Umezawa; Vadim N Biktashev; Claudia Kemper; Diana V Salakhieva; Gavin I Welsh; Nikolay V Kotov
Journal:  Immunology       Date:  2017-11-22       Impact factor: 7.397

3.  Discovery of a Napabucasin PROTAC as an Effective Degrader of the E3 Ligase ZFP91.

Authors:  Maha Hanafi; Xinde Chen; Nouri Neamati
Journal:  J Med Chem       Date:  2021-01-28       Impact factor: 7.446

4.  The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon.

Authors:  Maudry Laurent-Rolle; Juliet Morrison; Ricardo Rajsbaum; Jesica M Levingston Macleod; Giuseppe Pisanelli; Alissa Pham; Juan Ayllon; Lisa Miorin; Carles Martinez; Benjamin R tenOever; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2014-09-10       Impact factor: 21.023

5.  A STAT3-inhibitory hairpin decoy oligodeoxynucleotide discriminates between STAT1 and STAT3 and induces death in a human colon carcinoma cell line.

Authors:  Inès Souissi; Patrick Ladam; Jean A H Cognet; Stéphanie Le Coquil; Nadine Varin-Blank; Fanny Baran-Marszak; Valeri Metelev; Remi Fagard
Journal:  Mol Cancer       Date:  2012-03-16       Impact factor: 27.401

Review 6.  STAT3 inhibitors for cancer therapy: Have all roads been explored?

Authors:  Remi Fagard; Valeri Metelev; Inès Souissi; Fanny Baran-Marszak
Journal:  JAKSTAT       Date:  2013-01-01

7.  Identification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validation.

Authors:  Malgorzata Szelag; Anna Czerwoniec; Joanna Wesoly; Hans A R Bluyssen
Journal:  PLoS One       Date:  2015-02-24       Impact factor: 3.240

8.  A-to-I RNA editing of BLCAP lost the inhibition to STAT3 activation in cervical cancer.

Authors:  Wen Chen; Wenrong He; Hongbing Cai; Bicheng Hu; Caishang Zheng; Xianliang Ke; Li Xie; Zhenhua Zheng; Xinxing Wu; Hanzhong Wang
Journal:  Oncotarget       Date:  2017-06-13

9.  Identification of New Shikonin Derivatives as Antitumor Agents Targeting STAT3 SH2 Domain.

Authors:  Han-Yue Qiu; Xiang Zhu; Yue-Lin Luo; Hong-Yan Lin; Cheng-Yi Tang; Jin-Liang Qi; Yan-Jun Pang; Rong-Wu Yang; Gui-Hua Lu; Xiao-Ming Wang; Yong-Hua Yang
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

10.  Influence of Hyperglycemic Conditions on Self-Association of the Alzheimer's Amyloid β (Aβ1-42) Peptide.

Authors:  Sneha Menon; Neelanjana Sengupta
Journal:  ACS Omega       Date:  2017-05-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.